Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

VIRACEPT 625 MG TABLET

nelfinavir mesylate
$9.7224per EA

Strength

625 mg/1

Manufacturer

AGOURON

NDC

63010002770

Classification

Brand

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

6/20/2018

Active Ingredients

NELFINAVIR MESYLATE

Approval Type

New Drug (NDA)

FDA Application

NDA021503

On Market Since

4/30/2003

Pharmacological Classes

Cytochrome P450 3A Inhibitors
HIV Protease Inhibitors
Protease Inhibitor

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

0.0%

5Y

0.0%

All

+42.3%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

MYRBETRIQ ER 8 MG/ML SUSP
Brand
00469502099•Astellas Pharma US, Inc.
$2.2097
per ML
KALETRA 80 MG-20 MG/ML SOLN
Brand
00074395646•AbbVie Inc.
$3.1186
per ML
KATERZIA 1 MG/ML SUSPENSION
Brand
52652500101•Azurity Pharmaceuticals Inc.
$4.1914
per ML
KALETRA 200-50 MG TABLET
Brand
00074401412•AbbVie Inc.
$8.3041
per EA
KALETRA 200-50 MG TABLET
Brand
00074679922•AbbVie Inc.
$8.3041
per EA
NORVIR 100 MG TABLET
Brand
00074234030•AbbVie Inc.
$8.3462
per EA
EXFORGE HCT 5-160-25 MG TAB
Brand
00078056015•Novartis Pharmaceuticals Corporation
$8.4511
per EA
EXFORGE HCT 10-160-12.5 MG TAB
Brand
00078056115•Novartis Pharmaceuticals Corporation
$8.4532
per EA
EXFORGE HCT 5-160-12.5 MG TAB
Brand
00078055915•Novartis Pharmaceuticals Corporation
$8.5559
per EA
NORVASC 5 MG TABLET
Brand
00069153068•Pfizer Inc.
$8.6824
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy